亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

五方偉業藥化有限公司  

原料藥,藥物中間體,生化中間體,高端有機中間體,電子電池中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李女士
  • 電話:027-85836015
  • 郵件:sales3@whwfchem.com
  • QQ:2994847600
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 1,4丁烷磺內酯
1,4丁烷磺內酯
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2014-06-07 15:05
 
詳細信息
 別名:  1,4-丁烷磺內酯;1,4-丁烷磺酸內酯;1,4-丁磺酸內酯;1,4-丁烷磺內脂;1,4-丁基磺酸內酯
英文名稱:1,4-Butane sultone
CAS NO: 1633-83-6
分子量: 136.1695
EC NO:216-647-9
分子式:C4H8O3S Molecular Structure of 1633-83-6 (1,4-Butane sultone)
含量(%) ≥99.0
性質:本品為無色液體,能與多種有機溶劑混溶,不溶于水。相對密度1.331,熔點12.5-14.5℃,沸點134-136℃(0.53Kpa),折光率1.4640,閃點>110℃.
用途:本品主要用于物質含有丙烷磺酸集團的化學合成,產品純度高,副產品少,水分少于200PPm的高純度1.4BS可用作鋰電池電解液的添加劑,以改善電池的壽命和安全。
©2025 五方偉業藥化有限公司 版權所有   技術支持:化工網   訪問量:3148  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |